000			02225 a2200649 4500
005			20250517233714.0
264		0	_c20190208
008			201902s 0 0 eng d
022			_a1932-6203
024	7		_a10.1371/journal.pone.0202777 _2doi
040			_aNLM _beng _cNLM
100	1		_aHsieh, Yi-Chung
245	0	0	_aHepatic decompensation during paritaprevir/ritonavir/ombitasvir/dasabuvir treatment for genotype 1b chronic hepatitis C patients with advanced fibrosis and compensated cirrhosis. _h[electronic resource]
260			_bPloS one _c2018
300			_ae0202777 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_a2-Naphthylamine
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAnilides _xadministration & dosage
650	0	4	_aAntiviral Agents _xadministration & dosage
650	0	4	_aCarbamates _xadministration & dosage
650	0	4	_aCohort Studies
650	0	4	_aCyclopropanes
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGenotype
650	0	4	_aHepacivirus _xgenetics
650	0	4	_aHepatitis C, Chronic _xdrug therapy
650	0	4	_aHumans
650	0	4	_aHyperbilirubinemia _xchemically induced
650	0	4	_aLactams, Macrocyclic
650	0	4	_aLiver Cirrhosis _xdrug therapy
650	0	4	_aMacrocyclic Compounds _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aProline _xanalogs & derivatives
650	0	4	_aProspective Studies
650	0	4	_aRisk Factors
650	0	4	_aRitonavir _xadministration & dosage
650	0	4	_aSulfonamides _xadministration & dosage
650	0	4	_aSustained Virologic Response
650	0	4	_aTreatment Outcome
650	0	4	_aUracil _xadministration & dosage
650	0	4	_aValine
700	1		_aJeng, Wen-Juei
700	1		_aHuang, Chien-Hao
700	1		_aTeng, Wei
700	1		_aChen, Wei-Ting
700	1		_aChen, Yi-Cheng
700	1		_aLin, Shi-Ming
700	1		_aTai, Dar-In
700	1		_aLin, Chun-Yen
700	1		_aSheen, I-Shyan
773	0		_tPloS one _gvol. 13 _gno. 8 _gp. e0202777
856	4	0	_uhttps://doi.org/10.1371/journal.pone.0202777 _zAvailable from publisher's website
999			_c28759983 _d28759983